191 related articles for article (PubMed ID: 25479728)
21. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
22. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
23. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
Gao A; Peng Y; Deng Y; Qing H
Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
[TBL] [Abstract][Full Text] [Related]
24. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
[TBL] [Abstract][Full Text] [Related]
25. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
[TBL] [Abstract][Full Text] [Related]
27. Nonviral cell labeling and differentiation agent for induced pluripotent stem cells based on mesoporous silica nanoparticles.
Chen W; Tsai PH; Hung Y; Chiou SH; Mou CY
ACS Nano; 2013 Oct; 7(10):8423-40. PubMed ID: 24063246
[TBL] [Abstract][Full Text] [Related]
28. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
Ito D; Yagi T; Suzuki N
Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
[TBL] [Abstract][Full Text] [Related]
29. Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging.
Kooreman NG; Wu JC
J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S753-63. PubMed ID: 20880852
[TBL] [Abstract][Full Text] [Related]
30. Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases.
Chang EA; Jin SW; Nam MH; Kim SD
J Korean Neurosurg Soc; 2019 Sep; 62(5):493-501. PubMed ID: 31392877
[TBL] [Abstract][Full Text] [Related]
31. Cells derived from iPSC can be immunogenic - yes or no?
Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T
Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200
[TBL] [Abstract][Full Text] [Related]
32. Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.
Jiang Z; Han Y; Cao X
Cell Mol Immunol; 2014 Jan; 11(1):17-24. PubMed ID: 24336163
[TBL] [Abstract][Full Text] [Related]
33. Methods of induced pluripotent stem cells for clinical application.
Seki T; Fukuda K
World J Stem Cells; 2015 Jan; 7(1):116-25. PubMed ID: 25621111
[TBL] [Abstract][Full Text] [Related]
34. Stem Cell Therapies in Retinal Disorders.
Garg A; Yang J; Lee W; Tsang SH
Cells; 2017 Feb; 6(1):. PubMed ID: 28157165
[TBL] [Abstract][Full Text] [Related]
35. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
[TBL] [Abstract][Full Text] [Related]
36. Stem cell therapy for Parkinson's disease: safety and modeling.
Stoddard-Bennett T; Pera RR
Neural Regen Res; 2020 Jan; 15(1):36-40. PubMed ID: 31535640
[TBL] [Abstract][Full Text] [Related]
37. Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases.
Wan W; Cao L; Kalionis B; Xia S; Tai X
Stem Cells Int; 2015; 2015():382530. PubMed ID: 26240571
[TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cells as a source of hepatocytes.
Sauer V; Roy-Chowdhury N; Guha C; Roy-Chowdhury J
Curr Pathobiol Rep; 2014 Mar; 2(1):11-20. PubMed ID: 25650171
[TBL] [Abstract][Full Text] [Related]
39. Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability.
Fu X; Xu Y
Genome Med; 2012; 4(6):55. PubMed ID: 22741526
[TBL] [Abstract][Full Text] [Related]
40. Clinical potentials of human pluripotent stem cells in lung diseases.
Quan Y; Wang D
Clin Transl Med; 2014; 3():15. PubMed ID: 24995122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
